New Delhi, Oct. 28 -- The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, has released a list of 543 brands of anti-cancer medicines with their revised Maximum Retail Price (MRP).

As per the release, the revised MRPs will be effective from November 9. The revised price list reflects the information submitted by companies up to Tuesday, and it will be updated as and when manufacturers submit their revised prices of non-scheduled anti-cancer drugs.

Among the medicines listed, Anastrozole 1 mg tablets sold under the brand name Anarzole by RPG Life Sciences Ltd saw its MRP reduced from Rs 695.76 for a pack of 10 tablets to Rs 73.

Azacitidine 100 mg injection,...